申请人:Magis Farmaceutici s.r.l.
公开号:US04613602A1
公开(公告)日:1986-09-23
As a structural modification of the molecule of ranitidine, its 1-(4-methyl-piperazinyl) derivative has been synthesized. The product has shown to be active on the gastric secretion induced by histamine and on gastric and duodenal ulcers.
作为雷尼替丁分子的结构修饰,其1-(4-甲基哌嗪基)衍生物已被合成。该产物已被证明对组胺诱导的胃分泌和胃十二指肠溃疡具有活性。